Investing in quality driven and service focused businesses that improve patient outcomes.

The dynamics of an ageing population, rising patient expectations, and severe pressures on healthcare budgets, presents many challenges to the healthcare system.

Commissioners of healthcare and pharmaceutical services are increasingly looking at models that provide better patient outcomes for lower costs, and to embrace more innovative ways of working through better use of technology and patient pathway management.

Businesses that embrace changing models of service will continue to flourish and working with a partner like CBPE can help maximise their potential.

We invest across a range of areas, including: Healthcare services, medical technology (diagnostics, devices, and IT) and niche pharmaceuticals (services and products).

For more information, contact:

Investment Portfolio